These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21349594)

  • 1. Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients.
    Egede R; Jensen LO; Hansen HS; Antonsen L; Hansen KN; Junker A; Thayssen P
    Int J Cardiol; 2012 Jul; 158(3):376-9. PubMed ID: 21349594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI trial.
    Egede R; Jensen LO; Hansen HS; Hansen KN; Junker A; Thayssen P
    EuroIntervention; 2013 Feb; 8(10):1182-9. PubMed ID: 22987572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of therapy with rosuvastatin on lipid spectrum, factors of inflammation and endothelial function in patients with ischemic heart disease].
    Sergienko IV; Samoĭlenko EIu; Masenko VP; Ezhov MV; Sumarokov AB; Tkachev GA; Pogorelova OA; Balakhonova TV; Naumov VG
    Kardiologiia; 2006; 46(5):4-8. PubMed ID: 16858347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
    J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.
    Liu B; Zhang JY; Cao HM; Wang Q; Wang HB
    Intern Med; 2012; 51(10):1177-82. PubMed ID: 22687786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.
    Meek C; Wierzbicki AS; Jewkes C; Twomey PJ; Crook MA; Jones A; Viljoen A
    Curr Med Res Opin; 2012 Mar; 28(3):371-8. PubMed ID: 22256801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy improves brachial artery endothelial function in nephrotic syndrome.
    Dogra GK; Watts GF; Herrmann S; Thomas MA; Irish AB
    Kidney Int; 2002 Aug; 62(2):550-7. PubMed ID: 12110017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering efficacy of rosuvastatin.
    Adams SP; Sekhon SS; Wright JM
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010254. PubMed ID: 25415541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
    Durrington PN; Tuomilehto J; Hamann A; Kallend D; Smith K
    Diabetes Res Clin Pract; 2004 May; 64(2):137-51. PubMed ID: 15063607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial.
    Ridker PM; Genest J; Boekholdt SM; Libby P; Gotto AM; Nordestgaard BG; Mora S; MacFadyen JG; Glynn RJ; Kastelein JJ;
    Lancet; 2010 Jul; 376(9738):333-9. PubMed ID: 20655105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia.
    Gliozzi M; Walker R; Muscoli S; Vitale C; Gratteri S; Carresi C; Musolino V; Russo V; Janda E; Ragusa S; Aloe A; Palma E; Muscoli C; Romeo F; Mollace V
    Int J Cardiol; 2013 Dec; 170(2):140-5. PubMed ID: 24239156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function.
    Pirro M; Schillaci G; Romagno PF; Mannarino MR; Bagaglia F; Razzi R; Pasqualini L; Vaudo G; Mannarino E
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):14-21. PubMed ID: 19158317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event.
    Rawlings R; Nohria A; Liu PY; Donnelly J; Creager MA; Ganz P; Selwyn A; Liao JK
    Am J Cardiol; 2009 Feb; 103(4):437-41. PubMed ID: 19195498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effect of rosuvastatin treatment on HDL-subfraction phenotype in patients with primary hyperlipidemia.
    Kostapanos MS; Milionis HJ; Filippatos TD; Christogiannis LG; Bairaktari ET; Tselepis AD; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):5-13. PubMed ID: 19246334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
    Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
    Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Starting with rosuvastatin in primary hyperlipidemia--Is there more than lipid lowering?
    Milionis HJ; Gazi IF; Filippatos TD; Tzovaras V; Chasiotis G; Goudevenos J; Seferiadis K; Elisaf MS
    Angiology; 2005; 56(5):585-92. PubMed ID: 16193198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia.
    Demir V; Doğru MT; Ede H; Yilmaz S; Alp C; Celik Y; Yildirim N
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):162-166. PubMed ID: 29528361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.
    Timár O; Szekanecz Z; Kerekes G; Végh J; Oláh AV; Nagy G; Csiki Z; Dankó K; Szamosi S; Németh Á; Soltész P; Szücs G
    Arthritis Res Ther; 2013; 15(5):R105. PubMed ID: 24008003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX).
    Charbonneau F; Anderson TJ; Title L; Jobin J; Poirier P; Huyhn T; Chan S; Walling A; Hutchison S; Tran T; Lonn E; Buithieu J; Genest J
    Atherosclerosis; 2008 Mar; 197(1):420-7. PubMed ID: 17673219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.